A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2017-12-18
DOI
10.1080/10428194.2017.1410882
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic regulation of the RUNX transcription factor family has antitumor effects
- (2017) Ken Morita et al. JOURNAL OF CLINICAL INVESTIGATION
- Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
- (2016) Anuradha Illendula et al. EBioMedicine
- Antibacterial activities against rice bacterial leaf blight and tomato bacterial wilt of 2-mercapto-5-substituted-1,3,4-oxadiazole/thiadiazole derivatives
- (2015) Pei Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells
- (2015) Xiongwei Cai et al. Cell Stem Cell
- A small-molecule inhibitor of the aberrant transcription factor CBF -SMMHC delays leukemia in mice
- (2015) A. Illendula et al. SCIENCE
- Estrogen Defines the Dorsal-Ventral Limit of VEGF Regulation to Specify the Location of the Hemogenic Endothelial Niche
- (2014) Kelli J. Carroll et al. DEVELOPMENTAL CELL
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
- (2014) Nicholas Kwiatkowski et al. NATURE
- An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
- (2014) M. R. Mansour et al. SCIENCE
- Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors
- (2014) Nicolas Duployez et al. Expert Review of Hematology
- Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential
- (2013) R. C. DeKelver et al. BLOOD
- Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells
- (2013) Susumu Goyama et al. JOURNAL OF CLINICAL INVESTIGATION
- A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis
- (2013) Xiao-Jian Sun et al. NATURE
- Addiction of t(8;21) and inv(16) Acute Myeloid Leukemia to Native RUNX1
- (2013) Oren Ben-Ami et al. Cell Reports
- Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia
- (2012) Takaomi Sanda et al. CANCER CELL
- Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer
- (2012) Cornelia Johanna Franziska Scheitz et al. EMBO JOURNAL
- New insights into the role of Runx1 in epithelial stem cell biology and pathology
- (2012) Cornelia Johanna Franziska Scheitz et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBF interaction
- (2012) L. Cunningham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis
- (2011) Kentson Lam Frontiers in Bioscience-Landmark
- Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells
- (2011) Xiongwei Cai et al. PLoS One
- Irf8 regulates macrophage versus neutrophil fate during zebrafish primitive myelopoiesis
- (2010) L. Li et al. BLOOD
- Combinatorial Transcriptional Control In Blood Stem/Progenitor Cells: Genome-wide Analysis of Ten Major Transcriptional Regulators
- (2010) Nicola K. Wilson et al. Cell Stem Cell
- Structure of the AML1-ETO NHR3–PKA(RIIα) Complex and Its Contribution to AML1-ETO Activity
- (2010) Takeshi Corpora et al. JOURNAL OF MOLECULAR BIOLOGY
- The art of the chemical probe
- (2010) Stephen V Frye Nature Chemical Biology
- CBF is critical for AML1-ETO and TEL-AML1 activity
- (2009) L. Roudaia et al. BLOOD
- Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity
- (2009) S. Park et al. BLOOD
- Targeting the Notch1 and mTOR pathways in a mouse T-ALL model
- (2009) K. Cullion et al. BLOOD
- Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program
- (2009) M. Hoogenkamp et al. BLOOD
- Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis
- (2009) B. Jacob et al. BLOOD
- Hematopoietic Stem Cell Development Is Dependent on Blood Flow
- (2009) Trista E. North et al. CELL
- Mouse models of human AML accurately predict chemotherapy response
- (2009) J. Zuber et al. GENES & DEVELOPMENT
- Genetic Tests To Evaluate Prognosis and Predict Therapeutic Response in Acute Myeloid Leukemia
- (2009) Margaret L. Gulley et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The Osteogenic Transcription Factor Runx2 Controls Genes Involved in Sterol/Steroid Metabolism, Including Cyp11a1 in Osteoblasts
- (2009) Nadiya M. Teplyuk et al. MOLECULAR ENDOCRINOLOGY
- Transforming activity of AML1-ETO is independent of CBFβ and ETO interaction but requires formation of homo-oligomeric complexes
- (2009) Colin Kwok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Runx2 Regulates G Protein-coupled Signaling Pathways to Control Growth of Osteoblast Progenitors
- (2008) Nadiya M. Teplyuk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now